PARAMETER (N) | VALUE | (%) [Q1-Q3] |
---|---|---|
Patients | 32 | (100%) |
Sex: (32) | ||
Female | 14 | (44%) |
Male | 18 | (56%) |
Age | ||
Median | 30 | [22-40] |
Range | 2- | 59 |
Clinical presentation: | ||
Hematuria (28) | 22 | (79%) |
Microscopic | 18 | (64%) |
Macroscopic | 13 | (46%) |
Systemic arterial hypertension (26) | 18 | (69%) |
Non-nephrotic Proteinuria (28) | 17 | (61%) |
Nephrotic syndrome (28) | 11 | (39%) |
Laboratory tests: | ||
Proteinuria (g/24 h) (19) | 2.0 | [1.3-4.0] |
Serum albumin (g/dL) (31) | 3.1 | [3.0-4.0] |
Serum urea (mg/dL) (31) | 41 | [28-74] |
Serum creatinine (mg/dL) (31) | 1.1 | [0.9-2.5] |
Serum cholesterol (mg/dL) (16) | 214 | [179-288] |
Serum triglycerides (mg/dL) (16) | 208 | [109-344] |
MEST | N | UREA | CREATININE | ALBLBUMIN | CHOLESTEROL | TRIGLYCERIDES | 24 h PTU | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 32 | (100) | 41 | [28-74] | 1.1 | [0.9-2.5] | 3.1 | [3.0-4.0] | 213 | [179-288] | 208 | [109-344] | 2.0 | [1.3-4.0] |
M0 | 17 | (53) | 30 | [22-59]a a, b and c p < 0.05; | 1.0 | [0.8-1.9]b a, b and c p < 0.05; | 3.1 | [2.5-4.0] | 220 | [198-368] | 103 | [71-354] | 1.9 | [1.2-2.0] |
M1 | 15 | (47) | 67 | [36-85]a a, b and c p < 0.05; | 2.1 | [1.1-3.2]b a, b and c p < 0.05; | 3.1 | [3.0-4.0] | 187 | [172-259] | 212 | [201-335] | 2.3 | [2.2-4.7] |
E0 | 23 | (72) | 37 | [25-74] | 1.1 | [0.9-2.4] | 3.1 | [3.0-4.0] | 211 | [185-318] | 214 | [86-318] | 1.7 | [1.2-3.1] |
E1 | 9 | (28) | 42 | [36-83] | 1.6 | [0.9-2.5] | 3.6 | [3.0-4.0] | 216 | [173-269] | 202 | [125-350] | 2.3 | [2.0-5.1] |
S0 | 6 | (19) | 28 | [21-30] | 0.8 | [0.8-1.1] | 2.0 | [1.5-4.1] | 417 | [216-513] | 354 | [103-578] | 1.2 | [0.4-2.0] |
S1 | 26 | (81) | 46 | [31-74] | 1.4 | [0.9-3.0] | 3.1 | [3.0-4.0] | 189 | [173-249] | 204 | [115-283] | 2.2 | [1.5-4.0] |
T0 | 18 | (56) | 30 | [23-36]c a, b and c p < 0.05; ,d d and e p < 0.005. (%), [Q1-Q3]. | 0.9 | [0.8-1.1]e d and e p < 0.005. (%), [Q1-Q3]. | 3.5 | [2.4-4.0] | 216 | [189-308] | 216 | [100-354] | 1.5 | [1.2-2.2] |
T1 | 8 | (25) | 60 | [46-88]c a, b and c p < 0.05; | 2.0 | [1.3-2.8] | 3.1 | [2.8-3.6] | 173 | [170-225] | 204 | [201-514] | 3.0 | [1.9-5.1] |
T2 | 6 | (19) | 74 | [65-130]d d and e p < 0.005. (%), [Q1-Q3]. | 4.2 | [3.1-6.0]e d and e p < 0.005. (%), [Q1-Q3]. | 3.1 | [3.0-4.0] | 227 | [169-294] | 174 | [125-248] | 2.2 | [2.1-3.5] |
C0 | 25 | (78) | 39 | [79-28] | 1.1 | [2.8-0.8] | 4.0 | [4.0-3.0] | 189 | [249-173] | 208 | [335-103] | 2.0 | [2.8-1.3] |
C1 | 7 | (22) | 41 | [51-25] | 1.2 | [2.1-0.9] | 3.1 | [2.1-2.5] | 269 | [308-225] | 250 | [364-135] | 3.4 | [4.7-2.2] |